Cargando…

Development of a Practice Standard for Monitoring Adult Patients Receiving Bone-Modifying Agents at a Community Cancer Center

The purpose of this study is to develop a standard for monitoring outpatients starting bone-modifying agents (BMAs) at a community cancer center. The National Comprehensive Cancer Network (NCCN) and American Society of Clinical Oncology (ASCO) guidelines recommend the monitoring of serum magnesium a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Anton, Kalis, Joseph A., Sutz, Theresa R., Jeffers, Kate D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505660/ https://www.ncbi.nlm.nih.gov/pubmed/31186982

Ejemplares similares

Assessment of Initial Febrile Neutropenia Management in Hospitalized Cancer Patients at a Community Cancer Center
por: Goldsmith, Chelsea, et al.
Publicado: (2018)

Minimizing MRONJ after Tooth Extraction in Cancer Patients Receiving Bone-Modifying Agents
por: Avishai, Gal, et al.
Publicado: (2022)

2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice Standard
por: Mackler, Emily, et al.
Publicado: (2019)

Practical consensus recommendaton for adjuvant bone-modifying agents in breast cancer
por: Bharatuar, A., et al.
Publicado: (2018)

Universities and social innovation for global sustainable development as seen from the south
por: Arocena, Rodrigo, et al.
Publicado: (2021)

Prevalence of Precursory Signs of Atypical Femoral Fractures in Patients Receiving Bone‐Modifying Agents for Bone Metastases: A Cross‐Sectional Study
por: Kaku, Takumi, et al.
Publicado: (2023)

The role of bone‐modifying agents in myeloma bone disease
por: Lu, Huifang, et al.
Publicado: (2021)

Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US
por: McGrath, Leah J, et al.
Publicado: (2018)

Challenges of Integrating Biosimilars Into Clinical Practice
por: Jeffers, Kate, et al.
Publicado: (2020)

Review of Bone Modifying Agents in Metastatic Breast Cancer
por: Raghu Subramanian, Charumathi, et al.
Publicado: (2021)

Combination of Bone-Modifying Agents with Immunotarget Therapy for Hepatocellular Carcinoma with Bone Metastases
por: Chen, Zhaoyu, et al.
Publicado: (2022)

Bone-Modifying Agents in Early-Stage and Advanced Breast Cancer
por: Heeke, Arielle, et al.
Publicado: (2018)

CIRSE Standards of Practice on Thermal Ablation of Bone Tumours
por: Ryan, Anthony, et al.
Publicado: (2022)

Standard Practice for Acoustic Emission Monitoring During Continuous Welding
por: American Society for Testing and Materials. Philadelphia
Publicado: (2007)

Development of a Standardized Bone Marrow Procedure Training and Competency Toolkit for Advanced Practice Providers in a Large Community Oncology Practice
por: Lord, Katharine, et al.
Publicado: (2022)

Dasatinib as a Bone-Modifying Agent: Anabolic and Anti-Resorptive Effects
por: Garcia-Gomez, Antonio, et al.
Publicado: (2012)

Multicenter study on atypical femoral fractures in patients with bone metastases taking bone- modifying agents
por: Fukui, Tomoaki, et al.
Publicado: (2023)

Are Community Health Center Patients Interested in Self-Measured Blood Pressure Monitoring (SMBP) – And Can They Do It?
por: Roy, Debosree, et al.
Publicado: (2021)

Impact Analysis of Standardized GNSS Receiver Testing against Real-World Interferences Detected at Live Monitoring Sites
por: Bhuiyan, Mohammad Zahidul H., et al.
Publicado: (2019)

Standard Practice for Acoustic Emission Monitoring of Structures During Controlled Stimulation
por: American Society for Testing and Materials. Philadelphia
Publicado: (2007)

Standard Practice for Acoustic Emission Monitoring During Resistance Spot-Welding
por: American Society for Testing and Materials. Philadelphia
Publicado: (2007)

Modified Nanoparticles as Potential Agents in Bone Diseases: Cancer and Implant-Related Complications
por: Steckiewicz, Karol P., et al.
Publicado: (2020)

Use of bone‐modifying agents and clinical outcomes in older adults with multiple myeloma
por: Olszewski, Adam J., et al.
Publicado: (2019)

Osteonecrosis of the jaw (ONJ) in patients who receive Bone Targeting Agents (BTAs): the power of e-learning
por: Nicolatou-Galitis, Ourania, et al.
Publicado: (2018)

Correlates of Receiving Guideline-Concordant Postpartum Health Services in the Community Health Center Setting
por: Wouk, Kathryn, et al.
Publicado: (2022)

Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician survey
por: AlZahrani, Mashari, et al.
Publicado: (2020)

No Intentions in the Brain: A Wittgensteinian Perspective on the Science of Intention
por: Kalis, Annemarie
Publicado: (2019)

Resolved lower limb muscle tone abnormalities in children with HIV encephalopathy receiving standard antiretroviral therapy
por: Mann, Theresa N., et al.
Publicado: (2015)

Radiation therapy combined with bone-modifying agents ameliorates local control of osteolytic bone metastases in breast cancer
por: Tanaka, Hidekazu, et al.
Publicado: (2020)

Integrated monitoring: Setting new standards for the next decade of clinical trial practice
por: Rai, Kamala
Publicado: (2011)

Standard Practice for Continuous Monitoring of Acoustic Emission from Metal Pressure Boundaries
por: American Society for Testing and Materials. Philadelphia
Publicado: (2007)

Improvement of renal function by changing the bone-modifying agent from zoledronic acid to denosumab
por: Yamasaki, Mutsushi, et al.
Publicado: (2016)

Caring about bone-modifying agents (BMAs) in women with early-stage breast cancer
por: Shapiro, Charles L.
Publicado: (2020)

Two cases of atypical femoral fracture in cancer patients administered with bone-modifying agents
por: Fuchioka, Yusuke, et al.
Publicado: (2021)

ISR Standard Monitors
Publicado: (1975)

Comparison of the Respiratory Resistomes and Microbiota in Children Receiving Short versus Standard Course Treatment for Community-Acquired Pneumonia
por: Pettigrew, M. M., et al.
Publicado: (2022)

Daratumumab: Dawn of a New Paradigm in Multiple Myeloma?
por: Kalis, Joseph A.
Publicado: (2017)

Trifluridine/Tipiracil: Old Drug, New Tricks
por: Jeffers, Kate D.
Publicado: (2016)

A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents
por: Joppa, Stephanie A., et al.
Publicado: (2018)

An inclusive approach to raising standards in general practice: working with a 'community of practice' in Western Australia
por: Jiwa, Moyez, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_anjmdkqu9v09nq94cbrp8j2vhs